Spider Rock Advisors, LLC Axsome Therapeutics, Inc. Put Options Transaction History

Spider Rock Advisors, LLC

  • $6.17 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$78.93 - $95.84 $394,650 - $479,200
-5,000 Reduced 16.67%
25,000 $2.25 Million
Q1 2024

Apr 30, 2024
SELL
$69.39 - $97.64 $2.08 Million - $2.93 Million
-30,000 Reduced 50.0%
30,000 $2.39 Million
Q4 2023

Jan 30, 2024
BUY
$57.42 - $83.61 $3.45 Million - $5.02 Million
60,000 New
60,000 $3.08 Million

Others Institutions Holding AXSM

# of Institutions
325
Shares Held
37.7M
Call Options Held
912K
Put Options Held
855K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email